Dr. Reddy's Laboratories acquires Preferred A-1 shares of Edity Therapeutics
The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares
The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
his marks the 12th formulation facility under Akums, and the second in Baddi, a strategic move with an aim to enhance Akums’ manufacturing capabilities.
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices
Subscribe To Our Newsletter & Stay Updated